Literature DB >> 21303701

Different phospholipid transfer protein complexes contribute to the variation in plasma PLTP specific activity.

Marian C Cheung1, Gertrud Wolfbauer, John J Albers.   

Abstract

Phospholipid transfer protein (PLTP) facilitates the transfer of phospholipids among lipoproteins. Over half of the PLTP in human plasma has been found to have little phospholipid transfer activity (inactive PLTP). We recently observed that plasma PLTP specific activity is inversely correlated with high-density lipoprotein (HDL) level and particle size in healthy adults. The purpose of this study was to evaluate the factors that contribute to the variation in plasma PLTP specific activity. Analysis of the specific activity of PLTP complexes in nine plasma samples from healthy adults revealed two clusters of inactive PLTP complexes with mean molecular weights (MW) of 342kDa and 146kDa. The large and small inactive PLTP complexes represented 52±8% (range 39-63%) and 8±8% (range 1-28%) of the plasma PLTP, respectively. Active PLTP complexes had a mean MW of 207kDa and constituted 40±6% (range 33-50%) of the plasma PLTP. The specific activity of active PLTP varied from 16 to 32μmol/μg/h. These data demonstrate for the first time the existence of small inactive plasma PLTP complexes. Variation in the amount of the two clusters of inactive PLTP complexes and the specific activity of the active PLTP contribute to the variation in plasma PLTP specific activity.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21303701      PMCID: PMC3075333          DOI: 10.1016/j.bbalip.2011.02.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

Review 1.  Role of phospholipid transfer protein in high-density lipoprotein metabolism: insights from studies in transgenic mice.

Authors:  A Van Tol; M Jauhiainen; R De Crom; C Ehnholm
Journal:  Int J Tissue React       Date:  2000

2.  Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity.

Authors:  J Huuskonen; M Ekström; E Tahvanainen; A Vainio; J Metso; P Pussinen; C Ehnholm; V M Olkkonen; M Jauhiainen
Journal:  Atherosclerosis       Date:  2000-08       Impact factor: 5.162

3.  Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive.

Authors:  T Oka; T Kujiraoka; M Ito; T Egashira; S Takahashi; M N Nanjee; N E Miller; J Metso; V M Olkkonen; C Ehnholm; M Jauhiainen; H Hattori
Journal:  J Lipid Res       Date:  2000-10       Impact factor: 5.922

4.  Alpha-tocopherol modulates phosphatidylserine externalization in erythrocytes: relevance in phospholipid transfer protein-deficient mice.

Authors:  Alexis Klein; Valérie Deckert; Martina Schneider; Fabienne Dutrillaux; Arlette Hammann; Anne Athias; Naig Le Guern; Jean-Paul Pais de Barros; Catherine Desrumaux; David Masson; Xian-Cheng Jiang; Laurent Lagrost
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-07-06       Impact factor: 8.311

5.  Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement.

Authors:  Susan J Murdoch; Gertrud Wolfbauer; Hal Kennedy; Santica M Marcovina; Molly C Carr; John J Albers
Journal:  J Lipid Res       Date:  2002-02       Impact factor: 5.922

6.  Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation.

Authors:  Marian C Cheung; Tomás Vaisar; Xianlin Han; Jay W Heinecke; John J Albers
Journal:  Biochemistry       Date:  2010-08-31       Impact factor: 3.162

7.  Human apoA-I increases macrophage foam cell derived PLTP activity without affecting the PLTP mass.

Authors:  Marius R Robciuc; Jari Metso; Anca Sima; Christian Ehnholm; Matti Jauhiainen
Journal:  Lipids Health Dis       Date:  2010-06-09       Impact factor: 3.876

8.  Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins.

Authors:  Cecilia Oslakovic; Michael J Krisinger; Astra Andersson; Matti Jauhiainen; Christian Ehnholm; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2009-01-06       Impact factor: 5.157

9.  Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins.

Authors:  Marian C Cheung; John J Albers
Journal:  J Lipid Res       Date:  2006-03-06       Impact factor: 5.922

10.  Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.

Authors:  Marian C Cheung; Gertrud Wolfbauer; Hiroshi Deguchi; José A Fernández; John H Griffin; John J Albers
Journal:  Biochim Biophys Acta       Date:  2008-12-30
View more
  4 in total

1.  Structural basis of the lipid transfer mechanism of phospholipid transfer protein (PLTP).

Authors:  Meng Zhang; Xiaobo Zhai; Jinping Li; John J Albers; Simona Vuletic; Gang Ren
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-06-05       Impact factor: 4.698

2.  PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity.

Authors:  Daniel Seung Kim; Amber A Burt; Jane E Ranchalis; Simona Vuletic; Tomas Vaisar; Wan-Fen Li; Elisabeth A Rosenthal; Weijiang Dong; Jason F Eintracht; Arno G Motulsky; John D Brunzell; John J Albers; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2015-05-25       Impact factor: 5.922

Review 3.  Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Authors:  John J Albers; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-06-28

Review 4.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Authors:  Robert S Rosenson; H Bryan Brewer; W Sean Davidson; Zahi A Fayad; Valentin Fuster; James Goldstein; Marc Hellerstein; Xian-Cheng Jiang; Michael C Phillips; Daniel J Rader; Alan T Remaley; George H Rothblat; Alan R Tall; Laurent Yvan-Charvet
Journal:  Circulation       Date:  2012-04-17       Impact factor: 29.690

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.